April 29, 2025 02:27 PM EDT
Editor's note
Pharma

How phar­ma is re­act­ing to ‘Lib­er­a­tion Day’: Join us to­mor­row for Post-Hoc Live! 

Drew Armstrong

Executive Editor

To­mor­row at 12 p.m. ET, we’re go­ing to try some­thing new. We’re tak­ing Post-Hoc — our newslet­ter that brings you in­sight from our jour­nal­ists — and stream­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA de­lays PDU­FA date for small biotech, rais­ing ques­tions about im­pact of agency cuts

Pfiz­er CEO Bourla sug­gests phar­ma tar­iffs will fo­cus on US ad­ver­saries, not al­lies

Pfiz­er launch­es a new wave of cost cuts, ex­pects $7.7B in to­tal sav­ings through 2027

FDA ap­proves Abeona’s skin dis­ease cell ther­a­py

FDA won't re­or­ga­nize med­ical prod­uct cen­ters, Makary says in in­ter­view: 'I re­ject­ed that pro­pos­al'

sponsored

Rev­o­lu­tion­iz­ing obe­si­ty treat­ment: Could mi­to­chon­dria hold the key to un­lock­ing fat-spe­cif­ic weight loss?

A service from the Financial Times